Director of Oncology
Dr. Willumsen joined Nordic Bioscience in 2012 and assumed the position of department head in oncology in 2016. His research group focuses on the development of blood-based biomarkers to quantify tumor matrix in serum of cancer patients to understand pharmacodynamics/efficacy/resistance mechanisms of treatments. The group's research activities range from biomarker discovery to preclinical and clinical validation of results. In 2022, Dr. Willumsen was appointed as Director of Oncology.
H-index: 26. i10-index: 52. Citations: 2215 as of August 2024.
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
